In 2023, Pfizer plans to quadruple the price of its COVID-19 vaccine up to $130 per dose after the US government’s current purchase program expires.
The US government currently provides the vaccine free for all, paying around $30 per dose to Pfizer and German partner BioNTech.
In 2023, when the US public health emergency expires, the vaccine will be made available at no cost to people who have private insurance or government paid insurance.
Pfizer executive Angela Lukin says the new price will not be a barrier, but it is unclear what kind of access people without health insurance will have to the vaccine.
Pfizer expects the COVID-19 market to be about the size of the flu shot market for adults, while the pediatric market is based on shots given so far.
